Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

A quantitative approach to determining disease response during therapy using multiple biologic markers: application to carcinoma of the breast.

Woo KB, Waalkes TP, Ahmann DL, Tormey DC, Gehrke CW, Oliverio VT.

Cancer. 1978 May;41(5):1685-703. Review.

PMID:
348295
2.

The pharmacokinetics of [3H]-vincristine in man.

Bender RA, Castle MC, Margileth DA, Oliverio VT.

Clin Pharmacol Ther. 1977 Oct;22(4):430-5.

PMID:
902455
3.

Clinical pharmacology of anticancer drugs.

Chabner BA, Myers CE, Oliverio VT.

Semin Oncol. 1977 Jun;4(2):165-91. No abstract available.

PMID:
69319
4.

Pharmacology of anticancer drugs.

Oliverio VT.

Natl Cancer Inst Monogr. 1977 Mar;(45):57-61. No abstract available.

PMID:
927495
5.

Distribution and excretion of (3H)vincristine in the rat and the dog.

Castle MC, Margileth DA, Oliverio VT.

Cancer Res. 1976 Oct;36(10):3684-9.

6.

Pharmacology of the nitrosoureas: an overview.

Oliverio VT.

Cancer Treat Rep. 1976 Jun;60(6):703-7. No abstract available.

PMID:
821608
7.

Alteration of methotrexate uptake in human leukemia cells by other agents.

Bender RA, Bleyer WA, Frisby SA, Oliverio VT.

Cancer Res. 1975 May;35(5):1305-8.

8.

Uptake and binding of vincristine by murine leukemia cells.

Bleyer WA, Frisby SA, Oliverio VT.

Biochem Pharmacol. 1975 Mar 1;24(5):633-9. No abstract available.

PMID:
1168475
9.
10.
11.

Toxicology and pharmacology of the nitrosoureas.

Oliverio VT.

Cancer Chemother Rep 3. 1973 May;4(3):13-20. No abstract available.

PMID:
4201308
12.

Prediction of the distribution of methotrexate in the sting rays Dasyatidae sabrina and sayi by use of a model developed in mice.

Zaharko DS, Dedrick RL, Oliverio VT.

Comp Biochem Physiol A Comp Physiol. 1972 May 1;42(1):183-94. No abstract available.

PMID:
4402707
13.

Second Joint Working Conference: National Cancer Institute Chemotherapy Program. Working session report: pharmacology.

Oliverio VT.

Cancer Chemother Rep 3. 1972 May;3(1):69-71. No abstract available.

PMID:
4114997
14.

Studies of the metabolism of methotrexate by intestinal flora. I. Identification and study of biological properties of the metabolite 4-amino-4-deoxy-N 10 -methylpteroic acid.

Valerino DM, Johns DG, Zaharko DS, Oliverio VT.

Biochem Pharmacol. 1972 Mar 15;21(6):821-31. No abstract available.

PMID:
5014749
15.

Tissue distribution of folate antagonists.

Oliverio VT, Zaharko DS.

Ann N Y Acad Sci. 1971 Nov 30;186:387-99. Review. No abstract available.

PMID:
4943809
16.

Anergy and tryptophan metabolism in Hodgkin's disease.

DeVita VT, Chabner BA, Livingston DM, Oliverio VT.

Am J Clin Nutr. 1971 Jul;24(7):835-40. No abstract available.

PMID:
5091524
17.

Effects of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) and its degradation products on progression of L1210 cells through the cell cycle.

Bray DA, DeVita VT, Adamson RH, Oliverio VT.

Cancer Chemother Rep. 1971 Jun;55(3):215-20. No abstract available.

PMID:
5115843
18.

Methotrexate tissue distribution: prediction by a mathematical model.

Zaharko DS, Dedrick RL, Bischoff KB, Longstreth JA, Oliverio VT.

J Natl Cancer Inst. 1971 Apr;46(4):775-84. No abstract available.

PMID:
5573769
19.

Preliminary pharmacologic and clinical evaluation of camptothecin sodium (NSC-100880).

Gottlieb JA, Guarino AM, Call JB, Oliverio VT, Block JB.

Cancer Chemother Rep. 1970 Dec;54(6):461-70. No abstract available.

PMID:
4946015
20.

Reinvestigation of methotrexate metabolism in rodents.

Zaharko DS, Oliverio VT.

Biochem Pharmacol. 1970 Nov;19(11):2923-5. No abstract available.

PMID:
5512698
21.

The uptake, distribution, and antitumor activity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the murine glioma.

Levin VA, Shapiro WR, Clancy TP, Oliverio VT.

Cancer Res. 1970 Oct;30(10):2451-5. No abstract available.

22.

Pyridoxine and anergy in Hodgkin's disease.

Chabner P, DeVita VT, Livingston DM, Oliverio VT.

N Engl J Med. 1970 Jun 4;282(23):1326. No abstract available.

PMID:
5442374
23.

The absorption, distribution, excretion, and biotransformation of the carcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in animals.

Oliverio VT, Vietzke WM, Williams MK, Adamson RH.

Cancer Res. 1970 May;30(5):1330-7. No abstract available.

24.

Abnormalities of tryptophan metabolism and plasma pyridoxal phosphate in Hodgkin's disease.

Chabner BA, DeVita VT, Livingston DM, Oliverio VT.

N Engl J Med. 1970 Apr 9;282(15):838-43. No abstract available.

PMID:
5418547
25.

Plasma pyridoxal phosphate depletion by the carcinostatic procarbazine.

Chabner BA, DeVita VT, Considine N, Oliverio VT.

Proc Soc Exp Biol Med. 1969 Dec;132(3):1119-22. No abstract available.

PMID:
5360989
26.

Antibiotics alter methotrexate metabolism and excretion.

Zaharko DS, Bruckner H, Oliverio VT.

Science. 1969 Nov 14;166(3907):887-8.

PMID:
5345205
27.

The effect of organic acids on renal clearance of methotrexate in man.

Liegler DG, Henderson ES, Hahn MA, Oliverio VT.

Clin Pharmacol Ther. 1969 Nov-Dec;10(6):849-57. No abstract available.

PMID:
5349626
28.

A fluorometric method for determination of camptothecin in plasma and urine.

Hart LG, Call JB, Oliverio VT.

Cancer Chemother Rep. 1969 Sep;53(4):211-4. No abstract available.

PMID:
5384461
29.

Comparative carcinogenicity of N-isopropyl-alpha-(2-methylhydraziono)-p-toluamide. HCI (procarbazine hydrochloride), its degradation products, other hydrazines, and isonicotinic acid hydrazide.

Kelly MG, O'Gara RW, Yancey ST, Gadekar K, Botkin C, Oliverio VT.

J Natl Cancer Inst. 1969 Feb;42(2):337-44. No abstract available.

PMID:
5765465
30.

Characteristics of folic acid transport in the L1210 leukemia cell.

Lichtenstein NS, Oliverio VT, Goldman ID.

Biochim Biophys Acta. 1969;193(2):456-67. No abstract available.

PMID:
5389249
31.

Carrier-mediated transport of the folic acid analogue, methotrexate, in the L1210 leukemia cell.

Goldman ID, Lichtenstein NS, Oliverio VT.

J Biol Chem. 1968 Oct 10;243(19):5007-17. No abstract available.

32.

Antitumor activity and some pharmacologic properties of anthramycin methyl ether.

Adamson RH, Hart LG, DeVita VT, Oliverio VT.

Cancer Res. 1968 Feb;28(2):343-7. No abstract available.

PMID:
5641523
33.

The physiological disposition of the carcinostatic 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in man and animals.

DeVita VT, Denham C, Davidson JD, Oliverio VT.

Clin Pharmacol Ther. 1967 Jul-Aug;8(4):566-77. No abstract available.

PMID:
4951973
34.

Studies of resistance to methylglyoxal-bis-guanylhydrazone and its metabolic fate in tumor-bearing rodents.

Adamson RH, Denham C, Oliverio VT.

Arch Int Pharmacodyn Ther. 1966 Jun;161(2):364-74. No abstract available.

PMID:
5926878
35.

Monoamine oxidase inhibition by a new carcinostatic agent, N-isopropyl-a92-methylhydrazino)-p-toluamide (MIH).

De Vita VT, Hahn MA, Oliverio VT.

Proc Soc Exp Biol Med. 1965 Nov;120(2):561-5. No abstract available.

PMID:
4379192
36.

The metabolic fate of tritiated methotrexate. I. Absorption, excretion, and distribution in mice, rats, dogs and monkeys.

Henderson ES, Adamson RH, Denham C, Oliverio VT.

Cancer Res. 1965 Aug;25(7):1008-17. No abstract available.

37.

The metabolic fate of tritiated methotrexate. II. Absorption and excretion in man.

Henderson ES, Adamson RH, Oliverio VT.

Cancer Res. 1965 Aug;25(7):1018-24. No abstract available.

38.

THE PHYSIOLOGIC DISPOSITION OF DICHLOROMETHOTREXATE-C136 IN MAN.

DAVIDSON JD, OLIVERIO VT.

Clin Pharmacol Ther. 1965 May-Jun;6:321-7. No abstract available.

PMID:
14301766
39.

CLINICAL PHARMACOLOGY OF THE EFFECTIVE ANTITUMOR DRUGS.

OLIVERIO VT, ZUBROD CG.

Annu Rev Pharmacol. 1965;5:335-56. Review. No abstract available.

PMID:
14289708
40.
41.

CELLULAR ACCUMULATION OF METHYLGLYOXAL-BIS-GUANYLHYDRAZONE IN VITRO. I. GENERAL CHARACTERISTICS OF CELLULAR UPTAKE.

FIELD M, BLOCK JB, OLIVERIO VT, RALL DP.

Cancer Res. 1964 Dec;24:1939-46. No abstract available.

42.

SOME PHARMACOLOGIC PROPERTIES OF A NEW ANTITUMOR AGENT, N-ISOPROPYL-ALPHA-(2-METHYLHYDRAZINO)-P-TOLUAMIDE, HYDROCHLORIDE (NSC-77213).

OLIVERIO VT, DENHAM C, DEVITA VT, KELLY MG.

Cancer Chemother Rep. 1964 Nov;42:1-7. No abstract available.

PMID:
14226125
43.

CARCINOGENIC ACTIVITY OF A NEW ANTITUMOR AGENT, N-ISOPROPYL-ALPHA-(2-METHYLHYDRAZINO)-P-TOLUAMIDE, HYDROCHLORIDE (NSC-77213).

KELLY MG, O'GARA RW, GADEKAR K, YANCEY ST, OLIVERIO VT.

Cancer Chemother Rep. 1964 Jul;39:77-80. No abstract available.

PMID:
14201279
44.

THE DISTRIBUTION, EXCRETION, AND METABOLISM OF METHYLGLYOXAL-BIS-GUANYLHYDRAZONE-C14.

OLIVERIO VT, ADAMSON RH, HENDERSON ES, DAVIDSON JD.

J Pharmacol Exp Ther. 1963 Aug;141:149-56. No abstract available.

PMID:
14057906
45.

Concentration of methylglyoxal-bis-guanylhydrazone-C14 in mouse leukemia L1210 and a resistant variant.

ADAMSON RH, OLIVERIO VT, DENHAM C, VENDITTI JM.

Life Sci (1962). 1963 Jul;(7):493-6. No abstract available.

PMID:
14011036
46.

Synthesis of methylglyoxalbis-guanylhydrazone-C14.

OLIVERIO VT, DENHAM C.

J Pharm Sci. 1963 Feb;52:202-3. No abstract available.

PMID:
13940020
47.

Oxygen flask combustion in determination of C-14 and H3 in biological materials.

OLIVERIO VT, DENHAM C, DAVIDSON JD.

Anal Biochem. 1962 Aug;4:188-9. No abstract available.

PMID:
14481834
48.

The physiological disposition of dichloromethotrexate-C136 in animals.

OLIVERIO VT, DAVIDSON JD.

J Pharmacol Exp Ther. 1962 Jul;137:76-83. No abstract available.

PMID:
14481833
49.

Pharmacology of folic acid antagonists as related to brain and cerebrospinal fluid.

RALL DP, RIESELBACH RE, OLIVERIO VT, MORSE E.

Cancer Chemother Rep. 1962 Feb;16:187-90. No abstract available.

PMID:
14490033
50.

Synthesis of radioactive C136-dichloromethotrexate.

OLIVERIO VT, DAVIDSON JD.

J Pharm Sci. 1961 Apr;50:353-4. No abstract available.

PMID:
13730833

Supplemental Content

Loading ...
Support Center